Monday, 27 April 2009

Cardispan




Cardispan may be available in the countries listed below.


Ingredient matches for Cardispan



Levocarnitine

Levocarnitine is reported as an ingredient of Cardispan in the following countries:


  • Costa Rica

  • Guatemala

  • Honduras

  • Mexico

  • Nicaragua

  • Panama

International Drug Name Search

Sunday, 26 April 2009

Ranitidine-Glaxo Wellcome




Ranitidine-Glaxo Wellcome may be available in the countries listed below.


Ingredient matches for Ranitidine-Glaxo Wellcome



Ranitidine

Ranitidine is reported as an ingredient of Ranitidine-Glaxo Wellcome in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, 25 April 2009

Dolophine


Dolophine is a brand name of methadone, approved by the FDA in the following formulation(s):


DOLOPHINE HYDROCHLORIDE (methadone hydrochloride - injectable; injection)



  • Manufacturer: MYLAN INSTITUTIONAL

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG/ML [RLD]

DOLOPHINE HYDROCHLORIDE (methadone hydrochloride - tablet; oral)



  • Manufacturer: ROXANE

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [RLD][AA], 5MG [RLD][AA]

Has a generic version of Dolophine been approved?


Yes. The following products are equivalent to Dolophine:


methadone hydrochloride tablet; oral



  • Manufacturer: MALLINCKRODT

    Approval date: April 27, 2004

    Strength(s): 10MG [AA], 5MG [AA]


  • Manufacturer: SANDOZ

    Approval date: May 29, 1998

    Strength(s): 10MG [AA]


  • Manufacturer: THE PHARMANETWORK

    Approval date: November 25, 2009

    Strength(s): 10MG [AA]

METHADOSE (methadone hydrochloride tablet; oral)



  • Manufacturer: MALLINCKRODT

    Approval date: April 15, 1993

    Strength(s): 10MG [AA], 5MG [AA]

Note: No generic formulation of the following product is available.


  • methadone hydrochloride - injectable; injection

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dolophine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Dolophine.

See also...

  • Dolophine Consumer Information (Wolters Kluwer)
  • Dolophine Solution Consumer Information (Wolters Kluwer)
  • Dolophine Consumer Information (Cerner Multum)
  • Methadone Consumer Information (Drugs.com)
  • Methadone Consumer Information (Wolters Kluwer)
  • Methadone Concentrate Consumer Information (Wolters Kluwer)
  • Methadone Dispersible Tablets Consumer Information (Wolters Kluwer)
  • Methadone Solution Consumer Information (Wolters Kluwer)
  • Diskets Consumer Information (Cerner Multum)
  • Methadone Consumer Information (Cerner Multum)
  • Methadone Hydrochloride AHFS DI Monographs (ASHP)

Emadine


Emadine is a brand name of emedastine ophthalmic, approved by the FDA in the following formulation(s):


EMADINE (emedastine difumarate - solution/drops; ophthalmic)



  • Manufacturer: ALCON

    Approval date: December 29, 1997

    Strength(s): 0.05% [RLD]

Has a generic version of Emadine been approved?


No. There is currently no therapeutically equivalent version of Emadine available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Emadine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Ophthalmic compositions comprising emedastine and methods for their use
    Patent 5,441,958
    Issued: August 15, 1995
    Inventor(s): Yanni; John M. & Robertson; Stella M. & Okumura; Shigetoshi & Tanaka; Hitoshi & Saito; Tadayuki
    Assignee(s): Alcon Laboratories, Inc.
    Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating allergic conjunctivitis and related ailments.
    Patent expiration dates:

    • December 8, 2013
      ✓ 
      Patent use: TREATMENT OF ALLERGIC CONJUNCTIVITIS



See also...

  • Emadine Drops Consumer Information (Wolters Kluwer)
  • Emadine Consumer Information (Cerner Multum)
  • Emadine Advanced Consumer Information (Micromedex)
  • Emadine AHFS DI Monographs (ASHP)
  • Emedastine Drops Consumer Information (Wolters Kluwer)
  • Emedastine ophthalmic Consumer Information (Cerner Multum)
  • Emedastine Ophthalmic Advanced Consumer Information (Micromedex)
  • Emedastine Difumarate AHFS DI Monographs (ASHP)

Friday, 24 April 2009

Penovet




Penovet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Penovet



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penovet in the following countries:


  • Finland

  • Norway

  • Sweden

International Drug Name Search

Wednesday, 22 April 2009

Selenase




Selenase may be available in the countries listed below.


Ingredient matches for Selenase



Sodium Selenite

Sodium Selenite is reported as an ingredient of Selenase in the following countries:


  • Netherlands

  • Turkey

Sodium Selenite pentahydrate (a derivative of Sodium Selenite) is reported as an ingredient of Selenase in the following countries:


  • Austria

  • Germany

  • Switzerland

International Drug Name Search

Sunday, 19 April 2009

Eurax


Eurax is a brand name of crotamiton topical, approved by the FDA in the following formulation(s):


EURAX (crotamiton - cream; topical)



  • Manufacturer: RANBAXY

    Approved Prior to Jan 1, 1982

    Strength(s): 10% [RLD]

EURAX (crotamiton - lotion; topical)



  • Manufacturer: RANBAXY

    Approved Prior to Jan 1, 1982

    Strength(s): 10% [RLD][AT]

Has a generic version of Eurax been approved?


Yes. The following products are equivalent to Eurax:


CROTAN (crotamiton lotion; topical)



  • Manufacturer: SUMMERS

    Approved Prior to Jan 1, 1982

    Strength(s): 10% [AT]

Note: No generic formulation of the following product is available.


  • crotamiton - cream; topical

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Eurax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Eurax.

See also...

  • Eurax Consumer Information (Drugs.com)
  • Eurax Cream Consumer Information (Wolters Kluwer)
  • Eurax Lotion Consumer Information (Wolters Kluwer)
  • Eurax Consumer Information (Cerner Multum)
  • Eurax Topical Advanced Consumer Information (Micromedex)
  • Eurax AHFS DI Monographs (ASHP)
  • Crotamiton Cream Consumer Information (Wolters Kluwer)
  • Crotamiton Lotion Consumer Information (Wolters Kluwer)
  • Crotamiton topical Consumer Information (Cerner Multum)
  • Crotamiton Topical Advanced Consumer Information (Micromedex)
  • Crotamiton AHFS DI Monographs (ASHP)